Collegium Pharmaceutical (COLL) Other Non-Current Assets (2014 - 2026)

Collegium Pharmaceutical has reported Other Non-Current Assets for 13 years, with the latest figure at $15.2 million in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 296.28% year-over-year to $15.2 million in Q2 2026; TTM through Jun 2026 was $15.2 million, a 296.28% increase from a year earlier, with the FY2025 full-year figure at $20.2 million, up 141.31% from the prior year.
• Other Non-Current Assets was $15.2 million for Q2 2026 at Collegium Pharmaceutical, down from $16.1 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $20.2 million in Q4 2025, with the low at $1.0 million in Q2 2023.
• Average Other Non-Current Assets over 5 years is $5.2 million, with a median of $2.5 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets tumbled 58.89% in 2023, then jumped 699.24% in 2024.
• Over 5 years, Other Non-Current Assets stood at $2.5 million in 2022, then sank by 58.89% to $1.0 million in 2023, then surged by 699.24% to $8.4 million in 2024, then soared by 141.31% to $20.2 million in 2025, then fell by 24.54% to $15.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $15.2 million (Q2 2026), $16.1 million (Q1 2026), and $20.2 million (Q4 2025), per Business Quant data.